North America: Cannabis & Hemp

The DEA's marijuana rescheduling hearing raises critical questions about the future of cannabis regulation and what Schedule III classification could mean for businesses, investors, and the broader industry. Harris Sliwoski attorney Jason Adelstone joins industry experts to discuss the latest developments from the hearing and the legal and business implications companies should monitor as the federal rescheduling process unfolds.

North Carolina's House Bill 328 would fundamentally reshape the legal landscape for hemp-derived consumable products by introducing a strict 0.4 mg total THC cap per container and establishing age-21 purchase requirements. The proposed legislation would impose significant civil and criminal penalties on manufacturers, distributors, and retailers who fail to comply with the new standards taking effect in 2026.

The DEA's upcoming rescheduling hearings have sparked controversy over witness selection, while the Supreme Court's unanimous ruling on cannabis users' gun rights forces federal agencies to reconsider longstanding regulations. Meanwhile, reality TV's most famous survival competition draws the line at allowing cannabis use on set.